190 related articles for article (PubMed ID: 15144856)
1. Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.
Carter TL; Rissman RA; Mishizen-Eberz AJ; Wolfe BB; Hamilton RL; Gandy S; Armstrong DM
Exp Neurol; 2004 Jun; 187(2):299-309. PubMed ID: 15144856
[TBL] [Abstract][Full Text] [Related]
2. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease.
Ikonomovic MD; Sheffield R; Armstrong DM
Hippocampus; 1995; 5(5):469-86. PubMed ID: 8773259
[TBL] [Abstract][Full Text] [Related]
3. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
[TBL] [Abstract][Full Text] [Related]
4. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert.
Ikonomovic MD; Nocera R; Mizukami K; Armstrong DM
Exp Neurol; 2000 Dec; 166(2):363-75. PubMed ID: 11085901
[TBL] [Abstract][Full Text] [Related]
5. AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation.
Ikonomovic MD; Sheffield R; Armstrong DM
J Comp Neurol; 1995 Aug; 359(2):239-52. PubMed ID: 7499527
[TBL] [Abstract][Full Text] [Related]
6. Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.
Bossers K; Wirz KT; Meerhoff GF; Essing AH; van Dongen JW; Houba P; Kruse CG; Verhaagen J; Swaab DF
Brain; 2010 Dec; 133(Pt 12):3699-723. PubMed ID: 20889584
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of the hnRNP A2 and B1 in the hippocampal formations of brains with Alzheimer's disease.
Mizukami K; Ishikawa M; Iwakiri M; Ikonomovic MD; Dekosky ST; Kamma H; Asada T
Neurosci Lett; 2005 Sep; 386(2):111-5. PubMed ID: 15993539
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes.
Mizukami K; Ikonomovic MD; Grayson DR; Rubin RT; Warde D; Sheffield R; Hamilton RL; Davies P; Armstrong DM
Exp Neurol; 1997 Oct; 147(2):333-45. PubMed ID: 9344558
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
10. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease.
Ryoo HL; Joyce JN
J Comp Neurol; 1994 Oct; 348(1):94-110. PubMed ID: 7814686
[TBL] [Abstract][Full Text] [Related]
11. AMPA/kainate receptor gene expression in normal and Alzheimer's disease hippocampus.
Pellegrini-Giampietro DE; Bennett MV; Zukin RS
Neuroscience; 1994 Jul; 61(1):41-9. PubMed ID: 7969894
[TBL] [Abstract][Full Text] [Related]
12. Localization of non-N-methyl-D-aspartate glutamate receptors in normal and Alzheimer hippocampal formation.
Hyman BT; Penney JB; Blackstone CD; Young AB
Ann Neurol; 1994 Jan; 35(1):31-7. PubMed ID: 8285589
[TBL] [Abstract][Full Text] [Related]
13. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer disease. Evidence for hippocampal plasticity.
Armstrong DM; Ikonomovic MD
Mol Chem Neuropathol; 1996; 28(1-3):59-64. PubMed ID: 8871942
[TBL] [Abstract][Full Text] [Related]
14. Subunit-specific surface mobility of differentially labeled AMPA receptor subunits.
Kropf M; Rey G; Glauser L; Kulangara K; Johnsson K; Hirling H
Eur J Cell Biol; 2008 Oct; 87(10):763-78. PubMed ID: 18547676
[TBL] [Abstract][Full Text] [Related]
15. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease.
Rössler M; Zarski R; Bohl J; Ohm TG
Acta Neuropathol; 2002 Apr; 103(4):363-9. PubMed ID: 11904756
[TBL] [Abstract][Full Text] [Related]
16. AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease.
Armstrong DM; Ikonomovic MD; Sheffield R; Wenthold RJ
Brain Res; 1994 Mar; 639(2):207-16. PubMed ID: 8205474
[TBL] [Abstract][Full Text] [Related]
17. GluR2 AMPA receptor subunit expression in motoneurons at low and high risk for degeneration in amyotrophic lateral sclerosis.
Laslo P; Lipski J; Nicholson LF; Miles GB; Funk GD
Exp Neurol; 2001 Jun; 169(2):461-71. PubMed ID: 11358459
[TBL] [Abstract][Full Text] [Related]
18. Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1991 Feb; 29(2):162-7. PubMed ID: 1672808
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta decreases cell-surface AMPA receptors by increasing intracellular calcium and phosphorylation of GluR2.
Liu SJ; Gasperini R; Foa L; Small DH
J Alzheimers Dis; 2010; 21(2):655-66. PubMed ID: 20571220
[TBL] [Abstract][Full Text] [Related]
20. Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology.
Rissman RA; Mishizen-Eberz AJ; Carter TL; Wolfe BB; De Blas AL; Miralles CP; Ikonomovic MD; Armstrong DM
Neuroscience; 2003; 120(3):695-704. PubMed ID: 12895510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
